New 6-Month pill combo could beat Drug-Resistant TB
NCT ID NCT06649721
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 27 times
Summary
This study tests a 6-month, all-oral drug combination (BDLLfxC) for people with rifampin-resistant tuberculosis. About 120 teenagers and adults in China will take the pills and be followed for up to 72 weeks. The goal is to see if this shorter treatment can cure the infection safely, without the need for injections or longer therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY TUBERCULOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Anhui Chest Hospital
Hefei, Anhui, China
-
Beijing Chest Hospital
Beijing, China
-
Changsha Central Hospital
Changsha, Hunan, China
-
Harbin Chest Hospital
Harbin, Helongjiang, China
-
Hebei Chest Hospital
Shijiazhuang, Hebei, China
-
Henan Chest Hospital
Zhengzhou, Henan, China
-
Henan Infectious Disease Hospital
Zhengzhou, Henan, China
-
Huashan Hospital
Shanghai, China
-
Hulunbuir Infectious Disease Hospital
Hulunbuir, Inner Mongolia, China
-
Infectious Disease Hospital of Changchun
Changchun, Jilin, China
-
Infectious Disease Hospital of Heilongjiang Province
Harbin, Heilongjiang, China
-
Jiamusi Tuberculosis Hospital(Jiamusi Cancer Hospital)
Jiamusi, Heilongjiang, China
-
Jiangxi Chest Hospital
Nanchang, Jiangxi, China
-
Jilin Tuberculosis Hospital
Jilin, Jilin, China
-
Linyi People Hospital
Linyi, Shandong, China
-
Liupanshui Third People's Hospital
Liupanshui, Guizhou, China
-
Luoyang Center Hospital
Luoyang, Henan, China
-
Public Health Clinical Center of Chengdu
Chengdu, Sichuan, China
-
Qingdao Chest Hospital
Qingdao, Shandong, China
-
Shandong Public Health Clinical Center, Shandong University
Jinan, Shandong, China
-
Shanxi Medical University Affiliated Chest Hospital
Taiyuan, Shanxi, China
-
Shenyang Chest Hospital
Shenyang, Liaoning, China
-
The 8th Medical Center of Chinese PLA General Hospital
Beijing, Beijing Municipality, China
-
The Fifth Hospital of Shijiazhuang
Shijiazhuang, Hebei, China
-
The First Affiliated Hospital of Xiamen University
Xiamen, Fujian, China
-
The First Affiliated Hospital of Xinxiang Medical University
Xinxiang, Henan, China
-
The Fourth People's Hospital of Nanning
Nanning, Guangxi, China
-
The Second Hospital of Nanjing
Nanjing, Jiangsu, China
-
Tianjin Haihe Hospital
Tianjin, Tianjin Municipality, China
-
Weifang No.2 People's Hospital
Weifang, Shandong, China
-
Wenzhou Central Hospital
Wenzhou, Zhejiang, China
-
Wuhan Pulmonary Hospital，Wuhan Tuberculosis Prevention and Control Institute
Wuhan, Hubei, China
-
Xi'an Chest Hospital
Xi'an, Shaanxi, China
-
Yantai Qishan Hospital
Yantai, Shandong, China
Conditions
Explore the condition pages connected to this study.